Selected research
Industry Research
Transdermal Preparation Industry Research Report 2026
Market perspective
The global Transdermal Preparation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Transdermal Preparation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Transdermal Preparation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Transdermal Preparation include Novastage Pharmaceuticals (Shenzhen), Novartis, Luye Pharma Group, Hunan Jiudian Pharmaceutical, Harbin Hexinotai Pharmaceutical Technology, GSK, Demo Technology, Guangzhou Continent Biomedical Technology and Beijing Tide Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Transdermal Preparation market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transdermal Preparation Market by Company
Novastage Pharmaceuticals (Shenzhen)
Novartis
Luye Pharma Group
Hunan Jiudian Pharmaceutical
Harbin Hexinotai Pharmaceutical Technology
GSK
Demo Technology
Guangzhou Continent Biomedical Technology
Beijing Tide Pharmaceutical
Viatris
Transdermal Corporation
Nitto
MEDRx
Medpharm
ERCO Pharma
4P Therapeutics
Transdermal Preparation Segment by Type
Injectable Preparations
Non Injectable Preparations
Transdermal Preparation Segment by Application
Hospital
Clinic
Other
Transdermal Preparation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Preparation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transdermal Preparation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transdermal Preparation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transdermal Preparation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injectable Preparations
- Non Injectable Preparations
Applications
- Hospital
- Clinic
- Other
Companies covered
- Novastage Pharmaceuticals (Shenzhen)
- Novartis
- Luye Pharma Group
- Hunan Jiudian Pharmaceutical
- Harbin Hexinotai Pharmaceutical Technology
- GSK
- Demo Technology
- Guangzhou Continent Biomedical Technology
- Beijing Tide Pharmaceutical
- Viatris
- Transdermal Corporation
- Nitto
- MEDRx
- Medpharm
- ERCO Pharma
- 4P Therapeutics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Transdermal Preparation Market Size (2021-2032)
- 2.2.2 Global Transdermal Preparation Sales (2021-2032)
- 2.2.3 Global Transdermal Preparation Market Average Price (2021-2032)
- 2.3 Transdermal Preparation by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injectable Preparations
- 2.3.3 Non Injectable Preparations
- 2.4 Transdermal Preparation by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Transdermal Preparation Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Transdermal Preparation Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Transdermal Preparation Revenue of Manufacturers (2021-2026)
- 3.4 Global Transdermal Preparation Average Price by Manufacturers (2021-2026)
- 3.5 Global Transdermal Preparation Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Transdermal Preparation, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Transdermal Preparation, Product Type & Application
- 3.8 Global Manufacturers of Transdermal Preparation, Established Date
- 3.9 Global Transdermal Preparation Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novastage Pharmaceuticals (Shenzhen)
- 4.1.1 Novastage Pharmaceuticals (Shenzhen) Company Information
- 4.1.2 Novastage Pharmaceuticals (Shenzhen) Business Overview
- 4.1.3 Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Product Portfolio
- 4.1.5 Novastage Pharmaceuticals (Shenzhen) Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Transdermal Preparation Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Luye Pharma Group
- 4.3.1 Luye Pharma Group Company Information
- 4.3.2 Luye Pharma Group Business Overview
- 4.3.3 Luye Pharma Group Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Luye Pharma Group Transdermal Preparation Product Portfolio
- 4.3.5 Luye Pharma Group Recent Developments
- 4.4 Hunan Jiudian Pharmaceutical
- 4.4.1 Hunan Jiudian Pharmaceutical Company Information
- 4.4.2 Hunan Jiudian Pharmaceutical Business Overview
- 4.4.3 Hunan Jiudian Pharmaceutical Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hunan Jiudian Pharmaceutical Transdermal Preparation Product Portfolio
- 4.4.5 Hunan Jiudian Pharmaceutical Recent Developments
- 4.5 Harbin Hexinotai Pharmaceutical Technology
- 4.5.1 Harbin Hexinotai Pharmaceutical Technology Company Information
- 4.5.2 Harbin Hexinotai Pharmaceutical Technology Business Overview
- 4.5.3 Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Product Portfolio
- 4.5.5 Harbin Hexinotai Pharmaceutical Technology Recent Developments
- 4.6 GSK
- 4.6.1 GSK Company Information
- 4.6.2 GSK Business Overview
- 4.6.3 GSK Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GSK Transdermal Preparation Product Portfolio
- 4.6.5 GSK Recent Developments
- 4.7 Demo Technology
- 4.7.1 Demo Technology Company Information
- 4.7.2 Demo Technology Business Overview
- 4.7.3 Demo Technology Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Demo Technology Transdermal Preparation Product Portfolio
- 4.7.5 Demo Technology Recent Developments
- 4.8 Guangzhou Continent Biomedical Technology
- 4.8.1 Guangzhou Continent Biomedical Technology Company Information
- 4.8.2 Guangzhou Continent Biomedical Technology Business Overview
- 4.8.3 Guangzhou Continent Biomedical Technology Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Guangzhou Continent Biomedical Technology Transdermal Preparation Product Portfolio
- 4.8.5 Guangzhou Continent Biomedical Technology Recent Developments
- 4.9 Beijing Tide Pharmaceutical
- 4.9.1 Beijing Tide Pharmaceutical Company Information
- 4.9.2 Beijing Tide Pharmaceutical Business Overview
- 4.9.3 Beijing Tide Pharmaceutical Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Beijing Tide Pharmaceutical Transdermal Preparation Product Portfolio
- 4.9.5 Beijing Tide Pharmaceutical Recent Developments
- 4.10 Viatris
- 4.10.1 Viatris Company Information
- 4.10.2 Viatris Business Overview
- 4.10.3 Viatris Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Viatris Transdermal Preparation Product Portfolio
- 4.10.5 Viatris Recent Developments
- 4.11 Transdermal Corporation
- 4.11.1 Transdermal Corporation Company Information
- 4.11.2 Transdermal Corporation Business Overview
- 4.11.3 Transdermal Corporation Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Transdermal Corporation Transdermal Preparation Product Portfolio
- 4.11.5 Transdermal Corporation Recent Developments
- 4.12 Nitto
- 4.12.1 Nitto Company Information
- 4.12.2 Nitto Business Overview
- 4.12.3 Nitto Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Nitto Transdermal Preparation Product Portfolio
- 4.12.5 Nitto Recent Developments
- 4.13 MEDRx
- 4.13.1 MEDRx Company Information
- 4.13.2 MEDRx Business Overview
- 4.13.3 MEDRx Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 MEDRx Transdermal Preparation Product Portfolio
- 4.13.5 MEDRx Recent Developments
- 4.14 Medpharm
- 4.14.1 Medpharm Company Information
- 4.14.2 Medpharm Business Overview
- 4.14.3 Medpharm Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Medpharm Transdermal Preparation Product Portfolio
- 4.14.5 Medpharm Recent Developments
- 4.15 ERCO Pharma
- 4.15.1 ERCO Pharma Company Information
- 4.15.2 ERCO Pharma Business Overview
- 4.15.3 ERCO Pharma Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 ERCO Pharma Transdermal Preparation Product Portfolio
- 4.15.5 ERCO Pharma Recent Developments
- 4.16 4P Therapeutics
- 4.16.1 4P Therapeutics Company Information
- 4.16.2 4P Therapeutics Business Overview
- 4.16.3 4P Therapeutics Transdermal Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 4P Therapeutics Transdermal Preparation Product Portfolio
- 4.16.5 4P Therapeutics Recent Developments
5 Global Transdermal Preparation Market Scenario by Region
- 5.1 Global Transdermal Preparation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Transdermal Preparation Sales by Region: 2021-2032
- 5.2.1 Global Transdermal Preparation Sales by Region: 2021-2026
- 5.2.2 Global Transdermal Preparation Sales by Region: 2027-2032
- 5.3 Global Transdermal Preparation Revenue by Region: 2021-2032
- 5.3.1 Global Transdermal Preparation Revenue by Region: 2021-2026
- 5.3.2 Global Transdermal Preparation Revenue by Region: 2027-2032
- 5.4 North America Transdermal Preparation Market Facts & Figures by Country
- 5.4.1 North America Transdermal Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Transdermal Preparation Sales by Country (2021-2032)
- 5.4.3 North America Transdermal Preparation Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Transdermal Preparation Market Facts & Figures by Country
- 5.5.1 Europe Transdermal Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Transdermal Preparation Sales by Country (2021-2032)
- 5.5.3 Europe Transdermal Preparation Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Transdermal Preparation Market Facts & Figures by Country
- 5.6.1 Asia Pacific Transdermal Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Transdermal Preparation Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Transdermal Preparation Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Transdermal Preparation Market Facts & Figures by Country
- 5.7.1 South America Transdermal Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Transdermal Preparation Sales by Country (2021-2032)
- 5.7.3 South America Transdermal Preparation Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Transdermal Preparation Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Transdermal Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Transdermal Preparation Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Transdermal Preparation Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Transdermal Preparation Sales by Type (2021-2032)
- 6.1.1 Global Transdermal Preparation Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Transdermal Preparation Sales Market Share by Type (2021-2032)
- 6.2 Global Transdermal Preparation Revenue by Type (2021-2032)
- 6.2.1 Global Transdermal Preparation Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Transdermal Preparation Revenue Market Share by Type (2021-2032)
- 6.3 Global Transdermal Preparation Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Transdermal Preparation Sales by Application (2021-2032)
- 7.1.1 Global Transdermal Preparation Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Transdermal Preparation Sales Market Share by Application (2021-2032)
- 7.2 Global Transdermal Preparation Revenue by Application (2021-2032)
- 7.2.1 Global Transdermal Preparation Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Transdermal Preparation Revenue Market Share by Application (2021-2032)
- 7.3 Global Transdermal Preparation Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Transdermal Preparation Value Chain Analysis
- 8.1.1 Transdermal Preparation Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Transdermal Preparation Production Mode & Process
- 8.2 Transdermal Preparation Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Transdermal Preparation Distributors
- 8.2.3 Transdermal Preparation Customers
9 Global Transdermal Preparation Analyzing Market Dynamics
- 9.1 Transdermal Preparation Industry Trends
- 9.2 Transdermal Preparation Industry Drivers
- 9.3 Transdermal Preparation Industry Opportunities and Challenges
- 9.4 Transdermal Preparation Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst